ERBITUX
- Product NDC
- 66733-948
- 11-digit product format
- 667330948
- Labeler code
- 66733
- Product ID
- 66733-948_1cd448bd-5230-450c-ad4c-359e6d54cd2b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cetuximab
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- ImClone LLC
- Application
- BLA125084
- Marketing category
- BLA
- Marketing start
- 2004-02-12
- Substance
- CETUXIMAB
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ERBITUX
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CETUXIMAB | 2 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | PQX0D8J21J |
| Rxcui | 1657658, 1657660, 1657663, 1657664 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 0ff2bd88-bce9-4180-bdbf-b57a23b84f5f | Product name | 1 | 20161206 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66733-948-23 | 2024-01-30 | C162847 | 48780-1 | 1030e365-37c2-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use ERBITUX safely and effectively. See full prescribing information for ERBITUX. ERBITUX ® (cetuximab) injection, for intravenous use Initial U.S. Approval: 2004 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66733-948-23 | ERBITUX | 50 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 50 | 58 | |
| 66733-948-23 | ERBITUX | 1 in 1 CARTON | SOLUTION | 1 | 58 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66733-948-23 | ML - Milliliter | 66733-948 | c3dbba5c-336b-4ddb-9b90-ba481d62a52a | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| cetuximab | ACTIVE INGREDIENT | PQX0D8J21J | ERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC] | 34 | |
| cetuximab | ACTIVE MOIETY | PQX0D8J21J | ERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC] | 34 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC] | 34 | |
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INACTIVE INGREDIENT | 70WT22SF4B | ERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC] | 34 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC] | 34 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC] | 34 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1657658 | cetuximab 100 MG in 50 ML Injection | PSN | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657663 | cetuximab 200 MG in 100 ML Injection | PSN | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657660 | Erbitux 100 MG in 50 ML Injection | PSN | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657664 | Erbitux 200 MG in 100 ML Injection | PSN | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657664 | 100 ML cetuximab 2 MG/ML Injection [Erbitux] | SBD | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657660 | 50 ML cetuximab 2 MG/ML Injection [Erbitux] | SBD | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657663 | 100 ML cetuximab 2 MG/ML Injection | SCD | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657658 | 50 ML cetuximab 2 MG/ML Injection | SCD | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657658 | cetuximab 100 MG per 50 ML Injection | SY | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657663 | cetuximab 200 MG per 100 ML Injection | SY | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657660 | Erbitux 100 MG per 50 ML Injection | SY | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
| 1657664 | Erbitux 200 MG per 100 ML Injection | SY | 8bc6397e-4bd8-4d37-a007-a327e4da34d9 | 58 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 66733-948-23 | 66733094823 | 1 VIAL, SINGLE-DOSE in 1 CARTON (66733-948-23) / 50 mL in 1 VIAL, SINGLE-DOSE | 2004-02-12 | 0000-00-00 | No | No | Current |